Drug Shortage Report for APO-ANASTROZOLE
Report ID | 69444 |
Drug Identification Number | 02374420 |
Brand name | APO-ANASTROZOLE |
Common or Proper name | ANASTROZOLE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ANASTROZOLE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-12-10 |
Actual start date | 2018-12-10 |
Estimated end date | |
Actual end date | 2019-10-01 |
Shortage status | Resolved |
Updated date | 2019-10-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-10-08 | French | Compare |
v5 | 2019-10-08 | English | Compare |
v4 | 2018-12-13 | French | Compare |
v3 | 2018-12-13 | English | Compare |
v2 | 2018-12-12 | French | Compare |
v1 | 2018-12-12 | English | Compare |
Showing 1 to 6 of 6